Kreos Capital

BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. Its development pipeline includes motixafortide (BL-8040) for stem cell mobilization and solid tumors, AGI-134 for solid tumors, and BL-5010, a legacy product for the non-surgical removal of skin lesions. The company collaborates with major partners to evaluate combinations in cancer therapies, including MSD, a study with MD Anderson Cancer Center combining motixafortide with pembrolizumab in pancreatic cancer, and a Genentech collaboration to test motixafortide with atezolizumab in solid tumors. Headquartered in Israel, BioLineRx aims to advance its programs through clinical development and strategic alliances.

Abivax is a clinical-stage biotechnology company based in France, dedicated to developing innovative therapeutics that leverage the body's natural immune mechanisms to treat patients with autoimmune diseases, viral infections, and cancer. The company's primary focus is on chronic inflammatory diseases, particularly inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. Abivax is currently evaluating its leading drug candidate, obefazimod, in Phase 3 clinical trials aimed at addressing moderately to severely active ulcerative colitis. Through its drug development platforms, Abivax strives to deliver novel and effective treatments to patients with significant unmet medical needs in these therapeutic areas.

Crescendo Biologics develops innovative antibody therapeutics using its proprietary platforms. The company focuses on generating high-affinity, human VH antibody fragments for oncology and other indications. Its technology is based on a transgenic mouse platform that enables the creation of fully human VHH domain building blocks.

Sdui GmbH, founded in 2017 and based in Koblenz, Germany, is a rapidly growing education technology company that specializes in enhancing communication within educational institutions. The company offers a comprehensive digital platform designed to connect teachers, students, parents, and educational administrators through various intelligent features. Its solutions include tools for managing class schedules, parent communications, online class registrations, and room bookings, thereby streamlining administrative tasks and allowing educators to focus on delivering quality education. Sdui is committed to compliance with GDPR regulations, ensuring data protection while providing functionalities such as chat, translation, cloud services, and AI lesson planning tailored to the needs of schools and preschools. With its recent expansion through the acquisition of FoxEducation, Sdui now serves 22,000 educational institutions across over 70 countries, employing approximately 230 people.

FINBOURNE Technology Limited is a London-based company founded in 2016 that specializes in investment management technology. It has developed LUSID, a sophisticated investment data platform designed to transform and simplify how organizations manage their investment data. LUSID serves as an investment data store, providing comprehensive historical records of transactions and adjustments, thereby enhancing transparency and reducing costs associated with investing. The platform is built as a bitemporal engine and utilizes open APIs, allowing it to integrate seamlessly with existing operational systems and deliver agility and control. In addition to LUSID, the company offers Luminesce, a data virtualization engine that facilitates real-time data gathering and analysis. Together, these tools support a wide range of critical data management processes for various clients, from start-up managers to large global investment institutions, enabling them to achieve deeper insights and improved operational efficiency.

Ukio is a company that operates an apartment rental platform offering a selection of design-forward, turnkey apartments available for monthly stays. By providing fully furnished and serviced accommodations, Ukio simplifies the rental process, eliminating the challenges associated with traditional housing options, such as long-term contracts, moving logistics, and upfront costs like security deposits and broker fees. The company aims to deliver the comforts of home combined with the flexibility and convenience typically associated with hotel stays, catering to clients seeking a hassle-free living experience.

Beekeeper is a mobile-first communication platform designed for non-desk employees. It facilitates real-time messaging and targeted streams, automating processes and reducing reliance on paper. The platform connects frontline workers with various operational systems and communication channels, providing resources such as schedules and paystubs to improve employee engagement and retention.

Ibex Medical Analytics Ltd is a company based in Tel Aviv, Israel, that specializes in developing artificial intelligence-based systems for cancer diagnosis. Its flagship product, the Ibex Second Read system, operates alongside human pathologists, analyzing cases in parallel to identify discrepancies between the pathologist's diagnoses and its own analysis. By leveraging advancements in AI, data science, image analysis, and machine learning, Ibex aims to enhance clinical decision-making and streamline pathology laboratory workflows. The technology utilizes digitized glass slides and electronic medical records to uncover underlying patterns and extract clinical insights, ultimately enabling pathologists to provide rapid, objective, and accurate diagnoses. Through its innovative approach, Ibex strives to improve patient outcomes and quality of life in the field of cancer care.

Variantyx Inc. is a biotechnology company headquartered in Framingham, Massachusetts, that specializes in whole genome sequencing-based diagnostic testing. Founded in 2014, the company offers a comprehensive platform that includes its Genomic Unity® test, which identifies and reports all major types of genetic variants from a single patient sample. This test is designed to diagnose rare inherited disorders, providing a more efficient alternative to traditional genetic testing methods. Variantyx's technology enables hospitals and commercial laboratories to accurately analyze whole genome sequenced data, facilitating a better understanding of a patient's genetic makeup and leading to optimized treatment recommendations. The company's focus on genomic intelligence positions it at the forefront of precision medicine.

DataGuard is a privacy and compliance software-as-a-service company that helps businesses navigate national and international privacy regulations. Founded in 2017 and headquartered in Munich, Germany, DataGuard offers its Privacy-as-a-Service solution to over 1,000 clients, including small and medium-sized businesses as well as multinational enterprises. The platform provides a range of services, including auditing personal data flows, creating process documentation, managing data breaches, conducting third-party audits, handling data subject requests, and training employees. DataGuard caters to various industries, including industrials, technology, professional services, healthcare, finance, and government, enabling organizations to maintain compliance while focusing on their core operations.

BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. Its development pipeline includes motixafortide (BL-8040) for stem cell mobilization and solid tumors, AGI-134 for solid tumors, and BL-5010, a legacy product for the non-surgical removal of skin lesions. The company collaborates with major partners to evaluate combinations in cancer therapies, including MSD, a study with MD Anderson Cancer Center combining motixafortide with pembrolizumab in pancreatic cancer, and a Genentech collaboration to test motixafortide with atezolizumab in solid tumors. Headquartered in Israel, BioLineRx aims to advance its programs through clinical development and strategic alliances.

Latana Brand Tracking is a provider of cloud-based data technology that revolutionizes the brand tracking process. By utilizing proprietary mobile methodologies, the company focuses on collecting high-quality attitudinal data through millions of micro surveys distributed globally. This system allows for the real-time analysis of consumer attitudes, public opinion, and market trends, thereby offering valuable insights to research agencies, brands, consultancies, public institutions, and academia. Latana aims to eliminate guesswork in brand and marketing strategies, providing reliable data that empowers organizations to make informed decisions and optimize their campaigns, similar to the role Google Analytics plays in other marketing channels.

Gravitee.io develops an open-source API management platform that assists organizations in securing, publishing, and analyzing their APIs. The platform provides a user-friendly environment that consolidates various API management functions, including analytics dashboards, a developer portal, identity and access management, and security access tools. These features enable businesses to design, manage, deploy, and monitor their APIs in a secure and governed manner. Gravitee's solution is designed to be cost-effective, allowing organizations to access a comprehensive and secure interface for their API needs without incurring significant expenses.

Latana Brand Tracking is a provider of cloud-based data technology that revolutionizes the brand tracking process. By utilizing proprietary mobile methodologies, the company focuses on collecting high-quality attitudinal data through millions of micro surveys distributed globally. This system allows for the real-time analysis of consumer attitudes, public opinion, and market trends, thereby offering valuable insights to research agencies, brands, consultancies, public institutions, and academia. Latana aims to eliminate guesswork in brand and marketing strategies, providing reliable data that empowers organizations to make informed decisions and optimize their campaigns, similar to the role Google Analytics plays in other marketing channels.

Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.

Treasury Intelligence Solutions GmbH is a software provider based in Walldorf, Germany, specializing in smart payments solutions for medium-sized and large enterprises. Founded in 2010, the company offers a Software-as-a-Service platform that enhances the management of corporate payments, liquidity, and bank relationships on a global scale. Its flagship product, the Bank Transaction Manager, is a web-based, multi-bank-capable platform that integrates with SAP to streamline payment processes, ensuring efficiency, transparency, and security. Additional offerings include the Bank Account Manager, which serves as a central repository for managing global bank accounts, and the Bank Fee Manager, designed to control bank charges and analyze banking relationships. Treasury Intelligence Solutions has established a strategic alliance with Cashforce and is recognized for empowering CFOs and finance teams to optimize cash flow and payment functions through enhanced connectivity with banking systems and improved compliance measures. The company supports a vast network of banking options and manages significant daily cash volumes, fostering digital transformation across various industries.

Pyramid is what’s next in analytics. Our unified decision intelligence platform delivers insights for everyone to make faster, more informed decisions. It provides direct access to any data, enables governed self-service for any person, and serves any analytics need in a no-code environment. The Pyramid Decision Intelligence Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. The Pyramid Platform enables a strategic, organization-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Learn more www.pyramidanalytics.com

PolyPid Ltd. is a clinical-stage biopharmaceutical company headquartered in Petach Tikva, Israel, specializing in the development of advanced drug delivery systems based on its proprietary Polymer-Lipid Encapsulation MatriX (PLEX) technology. Founded in 2008, PolyPid's innovative platform allows for the entrapment of various active pharmaceutical ingredients (APIs) within a protective matrix, enabling controlled and prolonged release over extended periods, optimizing therapeutic regimens. The company’s product offerings include D-PLEX, an antibiotic reservoir designed to prevent surgical site infections, and several formulations aimed at addressing bone-related infections, such as BONYPID-1000 and BONYPID-500. PolyPid's technology supports localized drug administration across multiple therapeutic classes, highlighting its versatility in addressing diverse medical needs.

VectivBio AG is a clinical-stage biotechnology company based in Basel, Switzerland, founded in 2019 as a spinout from Therachon. The company specializes in the discovery, development, and commercialization of innovative treatments for severe rare diseases, particularly those with significant unmet medical needs. Its lead product candidate, Apraglutide, is a synthetic GLP-2 analog designed to enhance the intestine’s ability to absorb fluids and nutrients, thereby reducing the reliance on parenteral support in patients with short bowel syndrome. VectivBio is dedicated to developing best-in-disease therapies that aim to meaningfully improve the lives of patients and their families, providing more than just incremental advancements over existing standard-of-care options.

Moove is a fintech company specializing in mobility finance. It provides revenue-based vehicle financing to mobility entrepreneurs across Africa, democratizing vehicle ownership. Moove embeds alternative credit-scoring technology onto ride-hailing, logistics, and delivery platforms, using proprietary performance analytics to underwrite loans.

Moove is a fintech company specializing in mobility finance. It provides revenue-based vehicle financing to mobility entrepreneurs across Africa, democratizing vehicle ownership. Moove embeds alternative credit-scoring technology onto ride-hailing, logistics, and delivery platforms, using proprietary performance analytics to underwrite loans.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Numan is a digital platform focused on men's health, providing online access to medical professionals, prescription medications, at-home blood testing, and holistic health advice. The company addresses various health issues, including erectile dysfunction, premature ejaculation, hair loss, and nutritional deficiencies, through its integrated-care platform. By promoting accessible medical remedies, Numan empowers men to take control of their health and wellbeing, while also tackling the gender gap in healthcare-seeking behaviors. Through a combination of prescription medication, doctor consultations, and diagnostics, Numan offers a direct-to-consumer service that encourages men to confront health issues that impact their self-esteem and lifestyle choices.

NUMA Group is a Berlin-based European operator of a fully digitized hospitality platform that provides modern, design-focused accommodations and acts as a reliable partner for investors, owners, and developers. The company uses proprietary technology-based operator solutions that largely automate operational processes and improve cost efficiencies and revenues. NUMA operates more than 8,000 units across major European cities, including Berlin, London, Paris, Rome, Milan, Madrid, Barcelona, Oslo, Prague, and Vienna. The platform offers features such as electronic check-in, configured apartments with kitchen and workspace, professional housekeeping, and locally curated recommendations, enabling travelers to have an authentic experience and an alternative to boutique hotels and managed short-stay flats.

FintechOS is a leading fintech enablement platform that accelerates the launch and servicing of financial products. It breaks data free from core systems, allowing for personalized customer journeys at scale. FintechOS connects with any ecosystem tech or service and works with existing legacy tech. Headquartered in London and New York, it serves global clients such as Société Générale, Admiral Group, and BPCE Oney.

Voi Technology AB, established in 2018 and headquartered in Stockholm, Sweden, specializes in micro-mobility services. It offers electric scooters and bikes for urban commuters, promoting sustainable transportation through its mobile application.

HungryPanda is a food delivery and online marketplace that provides authentic Chinese cuisine and groceries to overseas Chinese communities. The platform, accessible via web, desktop, and mobile apps, lists participating Chinese restaurants and supermarkets and enables online ordering and payments. It supports merchant and consumer payments and delivers orders, forming an integrated food and retail ecosystem. Founded in 2016 and based in the United Kingdom, HungryPanda operates internationally with a broad footprint across multiple cities and countries, offering a one-stop solution for Chinese meals and groceries through a user-focused app and streamlined distribution network.

Biophytis SA is a clinical-stage biotechnology company headquartered in Paris, France, dedicated to developing therapeutics aimed at slowing the degenerative processes associated with aging and enhancing functional outcomes for patients with age-related diseases. The company is focused on activating key biological resilience pathways that may protect against the effects of various biological and environmental stresses linked to these diseases. Biophytis's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule designed for treating neuromuscular conditions such as sarcopenia and Duchenne muscular dystrophy. Additionally, its second candidate, Macuneos (BIO201), targets retinal diseases, including age-related macular degeneration and Stargardt disease. The company has established a collaboration agreement with AFM-Telethon to further the development of Sarconeos. Since its founding in 2006, Biophytis has aimed to position itself as a leader in the emerging field of aging science by providing innovative therapies for patients with limited treatment options.

Recharge is a Netherlands-based company specializing in online prepaid credit and top-up services. Operating from Amsterdam, it aims to simplify the traditionally slow and cumbersome process of online recharge, allowing consumers to quickly and securely acquire phone credit, prepaid credit, and gift cards. Through strategic partnerships with major brands, Recharge offers digital vouchers and manages a global network that facilitates easy access to these services. The company's mission is to become a leader in the online recharge market, making the process accessible anytime and anywhere for users worldwide.

EGYM is a global fitness technology company that empowers gym operators to deliver intelligent workout solutions through its connected gym equipment and software. It aims to enhance members' fitness journeys by providing data-based guidance, fostering physical and mental wellness.

Refurbed GmbH is an online marketplace based in Vienna, Austria, specializing in the distribution of refurbished electronic goods. Founded in 2017, the company offers a range of products including phones, TVs, tablets, smart watches, laptops, desktops, headphones, consoles, cameras, and kitchen appliances. Refurbed devices undergo a rigorous 40-step renewal process to ensure they look new and function like new. Each device comes with at least a 12-month guarantee. The company aims to provide products that are up to 40% cheaper and 100% more environmentally friendly than brand-new counterparts, making it an attractive option for cost-conscious and eco-friendly consumers.

Expertlead is a human resources technology company focused on the recruitment and technical qualification of IT professionals. It stands out by combining advanced technology with insights from a global community of tech experts to effectively identify, evaluate, and hire qualified candidates. The company employs a unique peer-to-peer interview process to assess the technical skills of applicants across various programming languages, leveraging collective intelligence to ensure the quality of potential hires. Additionally, Expertlead offers an innovative recruiting platform that provides clients with immediate access to a pool of thoroughly vetted freelancers specializing in software development, data science, product and project management, solution architecture, and UX/UI design. This holistic approach to tech recruiting enables organizations to efficiently meet their digital and technological talent needs.

Motus GI Holdings, Inc. is a medical technology company based in Fort Lauderdale, Florida, with operations in the United States and Israel. The company specializes in developing endoscopy solutions aimed at improving clinical outcomes and reducing costs associated with gastrointestinal conditions. Its primary product, the Pure-Vu System, is designed to assist in the cleaning of poorly prepared colons during colonoscopy procedures, thereby enhancing the overall patient experience and aiding in the early detection of colorectal cancer and other gastrointestinal diseases. The Pure-Vu System has received clearance from the U.S. Food and Drug Administration and holds CE marking for use in the European Economic Area.

Calliditas Therapeutics AB, headquartered in Stockholm, Sweden, is a specialty pharmaceutical company dedicated to developing high-quality medicines for patients with significant unmet medical needs in niche indications. The company focuses on the development and commercialization of Nefecon (also known as TARPEYO), a unique formulation designed to treat IgA nephropathy (IgAN), an inflammatory renal disease. This patented, locally acting formulation combines a time lag effect with a concentrated release of budesonide within a designated target area. Calliditas is conducting a global Phase 3 study for Nefecon and aims to commercialize it in the United States.

Grover is an online platform that allows consumers to rent a wide variety of tech products through monthly subscriptions. With a catalog of over 3,000 items, Grover offers access to smartphones, laptops, VR gear, wearables, and smart home appliances. The company's business model emphasizes sustainability by refurbishing and re-circulating returned products, thereby extending their lifespan and minimizing electronic waste. By enabling users to rent instead of purchase, Grover provides an affordable alternative for accessing consumer electronics. The company operates in multiple markets, including the United States, Germany, Austria, the Netherlands, and Spain.

PlusDental is a rapidly growing digital health startup based in Berlin, Germany, specializing in digital orthodontics. The company focuses on treating cosmetic cases of malocclusion, primarily through the use of clear aligners, which serve as a modern alternative to traditional braces. By leveraging advanced 3D technology and collaborating with leading orthodontists and dentists, PlusDental provides innovative solutions for correcting dental misalignments. The company aims to revolutionize aesthetic orthodontics in Europe by making treatments more convenient and affordable. PlusDental is committed to helping patients achieve brighter smiles through its user-friendly and versatile treatment methods, addressing the increasing demand for clear aligners in the global market.

Recharge is a Netherlands-based company specializing in online prepaid credit and top-up services. Operating from Amsterdam, it aims to simplify the traditionally slow and cumbersome process of online recharge, allowing consumers to quickly and securely acquire phone credit, prepaid credit, and gift cards. Through strategic partnerships with major brands, Recharge offers digital vouchers and manages a global network that facilitates easy access to these services. The company's mission is to become a leader in the online recharge market, making the process accessible anytime and anywhere for users worldwide.

TME Pharma is a clinical-stage biopharmaceutical company focused on enhancing cancer treatment by targeting the tumor microenvironment. The company develops biostable aptamers and mirror image nucleic acids, with its leading products, NOX-A12 and NOX-E36, classified as Spiegelmers. This innovative class of drugs offers specific advantages over traditional therapies, aiming to improve the effectiveness of cancer treatments. TME Pharma has also established a strategic alliance with Pfizer, Inc. The company is headquartered in Berlin, Germany, and is dedicated to advancing its research to benefit patients battling cancer.

NUMA Group is a Berlin-based European operator of a fully digitized hospitality platform that provides modern, design-focused accommodations and acts as a reliable partner for investors, owners, and developers. The company uses proprietary technology-based operator solutions that largely automate operational processes and improve cost efficiencies and revenues. NUMA operates more than 8,000 units across major European cities, including Berlin, London, Paris, Rome, Milan, Madrid, Barcelona, Oslo, Prague, and Vienna. The platform offers features such as electronic check-in, configured apartments with kitchen and workspace, professional housekeeping, and locally curated recommendations, enabling travelers to have an authentic experience and an alternative to boutique hotels and managed short-stay flats.

Essor is a growth platform for consumer brands, offering branding, acquisitions, sourcing, and marketing to help brands scale from startup to omnichannel global players. It delivers digital branding services, strategic consulting, and e-commerce growth solutions, leveraging technology and partnerships to expand reach. It manages a portfolio of health and wellness and lifestyle brands that are sold on Amazon, direct-to-consumer channels, and major retailers such as Target, CVS, and Walmart.

Quali is a software company that specializes in providing SaaS-based platform engineering tools. These tools are designed to assist enterprise DevOps and engineering teams in optimizing the continuous delivery of software at scale. By enhancing developer productivity and improving cloud governance, Quali's solutions help enterprises automate and improve their DevOps lifecycle. The company's platform utilizes cloud sandboxes, which are personal replicas of a production environment, to facilitate product lifecycle testing, management, and optimization. This enables various organizational units, including engineering, sales, and security, to increase productivity and efficiency while reducing costs.

Kandou Bus SA is a Swiss company focused on designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Kandou specializes in creating serial links that enhance data transfer speeds while minimizing power consumption across various applications, including DRAM, graphics cards, server backplanes, mobile devices, game consoles, routers, and FPGAs. The company's innovative approach allows for increased bit rates and extended reach in physical communications, enabling more efficient data transmission. By reducing energy requirements, Kandou's technology supports longer battery life and smaller device footprints, making it a vital player in the evolving landscape of electronics. The team comprises skilled scientists and engineers operating in Switzerland, the UK, and the US, dedicated to advancing the capabilities of serial link design.

Syte provides a visual search and product discovery platform that uses artificial intelligence to transform how retailers enable online shopping. The company's technology helps retailers improve site navigation and user experience through camera search, visual search, personalized recommendations, and smart merchandising tools, allowing shoppers to find visually similar products and discover complementary items quickly. By translating images into searchable product data, Syte supports intuitive shopping journeys that aim to engage shoppers and drive conversions across e-commerce sites.

Neuromod Devices, established in 2010 and headquartered in Dublin, Ireland, is a medical device company dedicated to the research and development of neuromodulation treatments for chronic tinnitus. The company's core product, the Mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the human nervous system. Neuromod's mission is to empower patients worldwide, including the 10% of adults affected by chronic tinnitus, by delivering targeted, non-invasive therapies that seamlessly integrate into daily life.

Abivax is a clinical-stage biotechnology company based in France, dedicated to developing innovative therapeutics that leverage the body's natural immune mechanisms to treat patients with autoimmune diseases, viral infections, and cancer. The company's primary focus is on chronic inflammatory diseases, particularly inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. Abivax is currently evaluating its leading drug candidate, obefazimod, in Phase 3 clinical trials aimed at addressing moderately to severely active ulcerative colitis. Through its drug development platforms, Abivax strives to deliver novel and effective treatments to patients with significant unmet medical needs in these therapeutic areas.

Bnext is a Madrid-based fintech platform that operates as a digital banking platform and marketplace for financial products. It enables users to open a current account quickly and connect external bank accounts and other financial information within a single app. Through a curated marketplace, users can access a range of financial and insurance products from selected fintechs and banks, compare offers, and purchase or manage products without leaving the app. The company emphasizes collaboration with its partners to provide competitive, well-matched options, including offerings across real estate investment, mutual funds, loans, crowdlending, and microloans. By aggregating accounts and products, Bnext aims to simplify personal finance and expand access to diverse financial services.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Zerto is a company that specializes in providing enterprise-class disaster recovery and business continuity software solutions. Founded in 2009 and headquartered in Boston, Massachusetts with additional offices globally, Zerto focuses on keeping IT infrastructure running continuously for both enterprises and cloud environments. Its flagship product, Zerto Virtual Replication, enables the protection, recovery, and migration of applications across various cloud and virtualized data centers. The company's BC/DR Platform offers disaster recovery as a service for public, private, and hybrid clouds, catering to industries such as healthcare, legal, and financial services.

Smava is a prominent credit comparison portal in Germany that facilitates connections between private borrowers and a diverse range of banks and private investors through its online platform. The company specializes in brokering loans, offering customers a variety of options in terms of amounts and interest rates, which allows for tailored loan solutions. In recent years, Smava has experienced significant growth, with its brokered loan volume increasing from approximately EUR 2 billion in 2018 to around EUR 2.7 billion in 2019, and further rising to about EUR 900 million in the first quarter of 2020 compared to the same period the previous year. To date, Smava has successfully brokered over EUR 8 billion in loans, underscoring its role as a key player in the online lending market.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Inotrem is a biotechnology company specializing in immunotherapy for acute and chronic inflammatory syndromes. It has developed a proprietary technology platform targeting the TREM-1 pathway to control unbalanced inflammatory responses, leading to the creation of nangibotide (LR12), a first-in-class TREM-1 inhibitor with potential applications in septic shock and myocardial infarction.

Funnel is a software company that specializes in marketing analytics and reporting tools designed to streamline data collection for online advertisers and e-commerce businesses. Founded in 2014 by Fredrik Skantze and Per Made, the company is headquartered in Stockholm and has an office in Boston. Funnel offers a platform that integrates seamlessly with over 400 marketing and advertising data sources, enabling users to automate the collection and organization of their advertising performance data. This integration allows businesses to easily transfer their data into various tools, such as Business Intelligence platforms, Data Warehouses, Google Sheets, and visualization tools. By providing a comprehensive overview of advertising expenditures and performance, Funnel helps businesses, including e-commerce companies, media agencies, B2B enterprises, mobile applications, and gaming firms, make informed decisions and predict future growth.

GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on the discovery and development of gene therapies for retinal degenerative diseases and neurodegenerative disorders of the central nervous system. Founded in 2012, the company utilizes innovative technologies, including mitochondrial targeting sequences and optogenetics, to develop treatments that aim to preserve or restore vision in patients with severe vision impairments. Its lead product candidates include GS010, an AAV2-based gene therapy that is currently undergoing Phase III clinical trials for Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is in Phase I/II trials for retinitis pigmentosa and geographic atrophy associated with dry age-related macular degeneration. GenSight Biologics is also advancing other product candidates in preclinical development targeting various ophthalmic and neurodegenerative conditions.

Voi Technology AB, established in 2018 and headquartered in Stockholm, Sweden, specializes in micro-mobility services. It offers electric scooters and bikes for urban commuters, promoting sustainable transportation through its mobile application.

Typelane AB, founded in 2016 and based in Stockholm, Sweden, develops tools to enhance employee experiences throughout their journey within a company, from onboarding to offboarding. The company offers products such as Journeys for managing onboarding and offboarding processes, and Conversations for facilitating communication with employees through chat interfaces. Typelane's services include onboarding surveys, employee profiles, company branding, offboarding support, and notifications at each step of the process. By focusing on smart workflows, intuitive design, and personalization, Typelane transforms traditionally manual and complex processes into easy and engaging experiences for both employers and employees.

MDxHealth is a molecular diagnostics company focused on developing and commercializing advanced epigenetic tests to assist in the detection and treatment of cancer. The company's product portfolio includes ConfirmMDx, a prostate cancer test aimed at addressing false-negative biopsy concerns; SelectMDx, which guides repeat biopsies for prostate cancer; AssureMDx, a noninvasive liquid biopsy test for bladder cancer; and PredictMDx for Glioblastoma, a tissue methylation test that aids in treatment decisions for brain cancer. Established in 2003 and headquartered in Irvine, California, with additional offices in Belgium and the Netherlands, MDxHealth leverages proprietary genomic and epigenetic technologies to provide actionable diagnostic information. The company's revenue is generated through clinical laboratory services and out-licensing of its patented DNA methylation platform and biomarkers, serving markets primarily in the United States and Europe.

Neuromod Devices, established in 2010 and headquartered in Dublin, Ireland, is a medical device company dedicated to the research and development of neuromodulation treatments for chronic tinnitus. The company's core product, the Mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the human nervous system. Neuromod's mission is to empower patients worldwide, including the 10% of adults affected by chronic tinnitus, by delivering targeted, non-invasive therapies that seamlessly integrate into daily life.

Kandou Bus SA is a Swiss company focused on designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Kandou specializes in creating serial links that enhance data transfer speeds while minimizing power consumption across various applications, including DRAM, graphics cards, server backplanes, mobile devices, game consoles, routers, and FPGAs. The company's innovative approach allows for increased bit rates and extended reach in physical communications, enabling more efficient data transmission. By reducing energy requirements, Kandou's technology supports longer battery life and smaller device footprints, making it a vital player in the evolving landscape of electronics. The team comprises skilled scientists and engineers operating in Switzerland, the UK, and the US, dedicated to advancing the capabilities of serial link design.

Founded in 2014, BUX is a fintech company headquartered in Amsterdam. It specializes in commission-free investing through its intuitive mobile platform, making stock trading accessible to both first-time and experienced investors.

Gett is a technology company that offers a cloud-based platform for corporate ground transportation management, integrating corporate fleets, ride‑hailing, taxi, and limousine services into a single interface. It helps businesses control spend, streamline booking, invoicing, and analytics, and improves employee experience. Founded in 2010, headquartered in London, with offices worldwide, it has raised over $750 million, including investment from Volkswagen Group, and employs more than 800 people.

Butternut Box is a UK-based startup founded by friends Kev and Dave, specializing in fresh, human-grade dog food made from real ingredients. The company emphasizes the quality and nutritional value of its meals, providing a personalized approach to dog nutrition. By collecting information on each dog's age, size, allergies, and dietary needs, Butternut Box tailors meal plans to meet the specific requirements of individual pets. This customer-centric model not only aims to enhance the health and well-being of dogs but also simplifies the feeding process for pet owners by delivering customized, homemade meals directly to their doors.

Nicox is a biopharmaceutical company based in Sophia Antipolis, France, focused on developing and commercializing nitric oxide (NO)-donating drugs for various health conditions, particularly inflammation and cardio-metabolic diseases. The company's primary product candidates include Naproxcinod, which is in Phase III trials for osteoarthritis, and NCX 6560, an NO-donating compound in Phase I trials targeting cardiovascular diseases. Additionally, Nicox's portfolio features several drugs in clinical development, such as PF-03187207 for glaucoma, TPI 1020 for respiratory disorders, and NCX 1510 for allergic rhinitis, all in Phase II trials. The company's pipeline also includes NCX 1047, aimed at treating skin disorders, and various NO-donors for conditions like diabetic retinopathy and hypertension. Collaborations with organizations such as Orexo AB, Pfizer Inc., and Merck & Co. further enhance its research and development capabilities. Founded in 1996, Nicox is dedicated to advancing innovative therapeutic solutions to improve patient outcomes in ophthalmology and beyond.

SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Quali is a software company that specializes in providing SaaS-based platform engineering tools. These tools are designed to assist enterprise DevOps and engineering teams in optimizing the continuous delivery of software at scale. By enhancing developer productivity and improving cloud governance, Quali's solutions help enterprises automate and improve their DevOps lifecycle. The company's platform utilizes cloud sandboxes, which are personal replicas of a production environment, to facilitate product lifecycle testing, management, and optimization. This enables various organizational units, including engineering, sales, and security, to increase productivity and efficiency while reducing costs.

Affluent Medical designs, develops, manufactures, and markets innovative implantable prostheses for the treatment of severe pathologies in urology and structural heart. Its product portfolio includes Kardiozis (for abdominal aortic aneurysm), Kalios/Epygon (for mitral insufficiency), and Artus (for urinary incontinence). Founded in 2011, it is headquartered in Paris, France.

Planday is a cloud-based software provider specializing in workforce management for various industries like hospitality, retail, and call centers. Its platform streamlines scheduling, considering factors such as staffing needs, budget, employee availability, and labor regulations. By automating these processes, Planday helps businesses reduce staff costs by 5%, decrease administration time by 75%, and enhance employee satisfaction by 20%.

Kiadis Pharma N.V. is a clinical-stage biopharmaceutical company based in Amsterdam, the Netherlands, specializing in the development of cell-based immunotherapy products for blood cancers and inherited blood disorders. The company is currently advancing its product pipeline, which includes K-NK002, an adjunctive immunotherapeutic in Phase II trials for blood cancer patients undergoing haploidentical hematopoietic stem cell transplants, and K-NK003, which is in Phase I/II trials for patients with acute myeloid leukemia who are relapsed or refractory. Additionally, Kiadis Pharma is developing K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company is engaged in collaborative efforts with multiple institutions to explore innovative treatments, including a combination of a monoclonal antibody and natural killer cells for COVID-19. Established in 1997, Kiadis Pharma addresses critical unmet medical needs in oncology through its innovative therapeutic approaches.

Abivax is a clinical-stage biotechnology company based in France, dedicated to developing innovative therapeutics that leverage the body's natural immune mechanisms to treat patients with autoimmune diseases, viral infections, and cancer. The company's primary focus is on chronic inflammatory diseases, particularly inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. Abivax is currently evaluating its leading drug candidate, obefazimod, in Phase 3 clinical trials aimed at addressing moderately to severely active ulcerative colitis. Through its drug development platforms, Abivax strives to deliver novel and effective treatments to patients with significant unmet medical needs in these therapeutic areas.

Signal AI is a technology platform that analyzes text to deliver market intelligence and actionable insights for business decision-making. It aggregates and analyzes data from digital, print, broadcast media, news, and regulatory sources to help organizations track competitive dynamics, monitor regulatory changes, and manage reputation. The platform employs machine learning to classify topics and surface trends, enabling users to derive insights and make faster, smarter decisions. Founded in 2013 and based in London, Signal AI focuses on media monitoring, reputation management, and regulatory compliance, supporting leaders in identifying risks and opportunities and informing strategic choices.

Signal AI is a technology platform that analyzes text to deliver market intelligence and actionable insights for business decision-making. It aggregates and analyzes data from digital, print, broadcast media, news, and regulatory sources to help organizations track competitive dynamics, monitor regulatory changes, and manage reputation. The platform employs machine learning to classify topics and surface trends, enabling users to derive insights and make faster, smarter decisions. Founded in 2013 and based in London, Signal AI focuses on media monitoring, reputation management, and regulatory compliance, supporting leaders in identifying risks and opportunities and informing strategic choices.

BioCatch is a pioneering company specializing in behavioral biometrics, which focuses on analyzing the digital behavior of online users to enhance fraud detection and prevention. By leveraging advanced cognitive science and machine learning, BioCatch provides insights that help financial institutions identify potential risks associated with user interactions while maintaining privacy. The company's technology is designed to combat increasingly sophisticated fraud tactics, including social engineering scams, and to streamline the digital banking experience from account creation to login and beyond. With over a decade of experience and a robust portfolio of patents, BioCatch is committed to driving innovation in the field of digital security, enabling clients to effectively combat fraud while fostering a trusted online environment.

Profile Pensions is a UK-based company dedicated to providing impartial pension advisory services aimed at enhancing individuals' understanding of their retirement savings. The firm offers accessible and affordable advice, ensuring that clients, regardless of their financial knowledge or status, can make informed decisions about their pensions. Profile Pensions assists in various aspects of pension management, including fund recommendations, pension tracing, and utilizing a pension calculator to help clients maximize their retirement wealth. By focusing on educating and empowering individuals, the company seeks to improve their financial futures and overall retirement outcomes.

Currencycloud is a global payments platform that simplifies the complexities of cross-border money transfers. It provides a foreign exchange payments automation solution, enabling businesses to transact in multiple currencies with ease. Through its API building blocks, developers can create customized payment solutions that integrate seamlessly into their products and services. The platform automates the end-to-end payment process, offering services for payment collection, currency conversion, and digital currency management. By managing the regulatory challenges of international payments, Currencycloud equips businesses across various industries with the tools necessary to embrace digital wallets and embed financial solutions into their operations, facilitating global expansion and enhancing their overall payment capabilities.

Mereo Biopharma, established in London in 2015, specializes in acquiring and advancing late-stage drug candidates from larger pharmaceutical companies. These candidates, often overlooked due to resource constraints, target rare and specialized diseases with significant unmet medical needs. Mereo's strategy involves rapidly progressing these assets through clinical development, either by partnering or divesting them, or directly commercializing them, particularly in orphan disease indications. The company combines operational efficiency with financial resources, leveraging a unique partnership with a leading global CRO, ICON, to conduct comprehensive clinical studies. Mereo's focus is on transforming the lives of patients worldwide by developing innovative medicines that can significantly improve their quality of life.

Kiadis Pharma N.V. is a clinical-stage biopharmaceutical company based in Amsterdam, the Netherlands, specializing in the development of cell-based immunotherapy products for blood cancers and inherited blood disorders. The company is currently advancing its product pipeline, which includes K-NK002, an adjunctive immunotherapeutic in Phase II trials for blood cancer patients undergoing haploidentical hematopoietic stem cell transplants, and K-NK003, which is in Phase I/II trials for patients with acute myeloid leukemia who are relapsed or refractory. Additionally, Kiadis Pharma is developing K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company is engaged in collaborative efforts with multiple institutions to explore innovative treatments, including a combination of a monoclonal antibody and natural killer cells for COVID-19. Established in 1997, Kiadis Pharma addresses critical unmet medical needs in oncology through its innovative therapeutic approaches.

Puls operates a platform that connects customers with a nationwide network of service providers delivering in-home repairs and installations. The company offers a range of home services, including handyman tasks such as furniture assembly, wall mounting and shelf installation, drywall repair, interior painting, appliance installation and repair, fan installation, and disinfection. It also provides TV mounting and setup, Wi-Fi configuration, and the installation of devices and systems, including garage doors and security systems, with same-day service options. Founded in 2015 and based in San Francisco, Puls positions itself as a scalable solution enabling convenient access to local technicians for on-demand home maintenance and device support.

Signal AI is a technology platform that analyzes text to deliver market intelligence and actionable insights for business decision-making. It aggregates and analyzes data from digital, print, broadcast media, news, and regulatory sources to help organizations track competitive dynamics, monitor regulatory changes, and manage reputation. The platform employs machine learning to classify topics and surface trends, enabling users to derive insights and make faster, smarter decisions. Founded in 2013 and based in London, Signal AI focuses on media monitoring, reputation management, and regulatory compliance, supporting leaders in identifying risks and opportunities and informing strategic choices.

Cellnovo is a medical device company focused on diabetes management. The company develops and markets an integrated system that connects various components of diabetes care through mobile technology. Its product portfolio includes a cordless micro-pump, an integrated monitoring device, and a cellular handset equipped with a touch screen and an embedded blood glucose meter. This innovative system allows for automatic data transmission, enabling patients and healthcare providers to effectively monitor the patient's condition in real-time.

TME Pharma is a clinical-stage biopharmaceutical company focused on enhancing cancer treatment by targeting the tumor microenvironment. The company develops biostable aptamers and mirror image nucleic acids, with its leading products, NOX-A12 and NOX-E36, classified as Spiegelmers. This innovative class of drugs offers specific advantages over traditional therapies, aiming to improve the effectiveness of cancer treatments. TME Pharma has also established a strategic alliance with Pfizer, Inc. The company is headquartered in Berlin, Germany, and is dedicated to advancing its research to benefit patients battling cancer.

ROLI is a music technology company that specializes in creating innovative hardware and software solutions for music learning and creation. The firm develops a modular music creation system that features a three-dimensional pressure-sensing digital keyboard, designed to enhance musical expression by responding to variations in pressure. ROLI's team, composed of musicians, programmers, teachers, anthropologists, engineers, and artists, is dedicated to redefining how individuals engage with music through their products, which include a range of music-making devices, software, sounds, and accessories. By focusing on the intersection of technology and music, ROLI aims to make music more accessible and expressive for users of all skill levels.

Proveca Ltd. is a pharmaceutical company based in Daresbury, United Kingdom, founded in 2010. The company specializes in identifying, researching, and licensing off-patent medicines aimed at addressing unmet medical needs, particularly within the pediatric market. Proveca's product portfolio includes formulations for conditions such as sialorrhoea, epilepsy, heart failure, and acute pain management. By developing the necessary clinical data and formulations, Proveca aims to secure Paediatric Use Marketing Authorisation (PUMA), which provides a decade of market protection, along with the potential to obtain Orphan Drug status for additional market exclusivity. The company seeks to commercialize its licensed medicines or sell licenses to larger pharmaceutical firms, ensuring that essential treatments are accessible to children in appropriate formats.

SoundCloud, established in 2008 by Alexander Ljung and Eric Wahlforss, is a global social sound platform that enables users to create, share, and discover music. It offers a vast selection of audio content from a diverse creator community, facilitated by an open platform that directly connects creators with their fans worldwide. Users can instantly record, upload, and share sounds, while also accessing detailed statistics and community feedback.

CrossLend GmbH is a Berlin-based company founded in 2014 that operates an online lending platform specializing in digital credit mediation and financing. The company facilitates cross-border credit mediation by partnering with a bank, enabling investments across Europe through a single platform. CrossLend's platform connects private and institutional investors from low-interest rate countries with borrowers from high-interest rate countries, effectively intermediating loans and securitizing them into bonds for investment. This model allows investors to achieve favorable risk-return profiles while providing borrowers with competitive interest rates. Additionally, CrossLend offers a range of financing options, including consumer loans, development loans, invoices, mortgages, SME loans, and bridging loans, supported by its digital infrastructure and commitment to standardization in the lending process.

Teridion provides cloud-based wide-area network services that optimize global connectivity for enterprises and SaaS companies. The company operates a WAN as a service platform with more than 500 points of presence and partnerships with over 25 public clouds, enabling stable, high-performance connectivity across regions, including mainland China. It requires no hardware or software installation, works with any edge device, and is scalable to support growing networks. Teridion uses proprietary algorithms to direct traffic to optimal entry points while accounting for bandwidth, latency, and geography, and it supplies a real-time congestion map to sustain performance. By managing middle-mile routing, it can deliver substantially higher throughput than the public Internet—up to 20 times in some scenarios—and its interoperable design allows integration with additional backend and security solutions to fit into existing cloud architectures.

BONESUPPORT AB is a medical technology company based in Lund, Sweden, specializing in the development of injectable bioceramic bone graft substitutes aimed at treating fractures and bone voids resulting from trauma, infection, disease, or surgery. Founded in 1999, the company offers a range of products, including CERAMENT BONE VOID FILLER, CERAMENT G, and CERAMENT V. These products are designed to address various medical conditions such as chronic osteomyelitis and infected diabetic foot ulcers. CERAMENT G and CERAMENT V are antibiotic-eluting bone graft substitutes that enhance bone healing, utilizing gentamicin and vancomycin, respectively. BONESUPPORT operates additional locations in Frankfurt, Zurich, London, Boston, and Haryana, India, and is committed to improving the quality of life for patients with bone disorders through innovative biomaterial solutions.

Electro Power Systems operates in the sustainable energy sector, focusing on hybrid-storage solutions and microgrids that convert intermittent renewable energy into a reliable power source. Headquartered in Paris, with research, development, and manufacturing facilities in Italy, the company has developed innovative hybrid energy storage technologies, supported by 125 patents and over a decade of research and development. These solutions are designed to stabilize electrical grids with high levels of renewable energy integration in developed countries and provide cost-effective off-grid power in emerging economies without relying on subsidies. Electro Power Systems has successfully implemented and is commissioning 36 large-scale projects, including off-grid hybrid systems and grid support systems, totaling over 47 MWh of capacity across 21 countries, serving more than 165,000 customers daily.

Pixium Vision SA is a bioelectronics company based in Paris, France, focused on developing innovative implantable medical devices aimed at restoring vision for individuals blinded by the degeneration of photoreceptor cells in the retina. The company’s flagship product, the PRIMA System, is a bionic vision system designed to improve visual acuity and enhance the independence of patients. Pixium Vision also works on the Intelligent Retinal Implantable System (IRIS1), which is currently undergoing clinical trials, and is developing two subsequent generations, IRIS2 and IRIS3, each designed to provide improved visual capabilities through advanced technologies. Founded in 2011 as a spin-out from the Vision Institute and Université Pierre et Marie Curie, Pixium collaborates with prestigious institutions such as Stanford University and Moorfields Eye Hospital to further its research and development efforts in retinal implant systems.

Since 2012 Reduxio has redefined data management and data protection, and the company has evolved its mission to deliver the first microservices-based storage and data platform for stateful applications. Reduxio’s cloud data platform for Kubernetes pairs high performance software-defined container-native storage and data management with data mobility to enable customers to build a single data cloud for their applications across all their infrastructure, anywhere. Reduxio is backed by Intel Capital, C5 Capital Cloud Partners and Jerusalem Venture Partners (JVP).

Searchmetrics, established in 2007, is a global provider of search data, software, and consulting solutions. Headquartered in Berlin, Germany, with offices in the US, UK, and Croatia, the company specializes in enterprise SEO and content marketing. Its flagship product, Searchmetrics Suite, offers a SaaS solution that empowers businesses to analyze their SEO performance, understand competitors' strategies, and optimize content using real-time data. The suite comprises four modules: Research Cloud, Content Experience, Search Experience, and Site Experience. Additionally, Searchmetrics provides consulting services through its Digital Strategies Group, helping large brands excel in digital marketing. The company's offerings also include Searchmetrics Insights, which delivers unique market research through exclusive search data metrics, and an API for integrating search engine rankings and other marketing analytics into enterprise applications.

Zooz is a technology company founded in 2010 that specializes in developing a payments platform aimed at enhancing the payment performance of merchants. The platform offers an integrated solution that includes acquirers, e-wallets, alternative payment methods, and fraud management services. By routing transactions through the entire payment process, Zooz enables businesses to optimize and streamline their payment operations within a complex ecosystem. In July 2018, Zooz was acquired by PayU, further expanding its capabilities and reach in the payments landscape.

Savedo GmbH is an online marketplace based in Berlin, Germany, that allows users in Germany, Austria, and the Netherlands to invest in fixed-term deposits across the European Union. Founded in 2014, the company operates as a subsidiary of Deposit Solutions GmbH. Savedo's platform facilitates safe and efficient investment in retail financial products by providing better interest rates and handling customer service for participating banks. It offers standardized account documents, enabling clients to invest easily in various European markets without the need to travel. The company is supported by a team of experienced finance specialists and online professionals.

Marley Spoon Inc., operating under the name Marley Spoon, is a meal kit service established in 2014 and headquartered in New York, New York. The company specializes in delivering weekly meal kits that include pre-portioned ingredients and recipes directly to customers' doors, enabling them to prepare home-cooked meals. As a subsidiary of Marley Spoon AG, the company focuses on providing a convenient culinary experience, allowing customers to enjoy a variety of dishes without the hassle of grocery shopping.

Widespace AB, established in 2007, is a Swedish-based digital advertising company specializing in mobile branding campaigns. It operates Summit, a programmatic ad platform and marketplace, offering inventory marketplace, ad formats and serving, data marketplace, and reporting solutions. Widespace caters to media buyers and publishers, facilitating the purchase and sale of advertising inventory. With headquarters in Stockholm, it maintains offices across Europe, including Amsterdam, Copenhagen, Helsinki, London, Milan, Warsaw, Oslo, and Paris. As of 2018, it operates as a subsidiary of Sellbranch AB.

Lifeward is a medical device company that designs, develops, and commercializes solutions for physical rehabilitation and recovery. Its product line includes the ReWalk Exoskeleton, ReStore Exo-Suit, MyoCycle FES bikes, and AlterG Anti-Gravity systems, which provide functional and health benefits in clinical settings as well as in home and community environments. The company operates in the United States, Israel, and Germany, and was founded in 2001 in Marlborough, Massachusetts.

ChannelSight optimizes e-commerce sales for brands by connecting consumers with retailers via a 'Buy Now' service. It offers solutions across various digital channels, serving sectors like video games, FMCG, fashion, and electronics. Headquartered in Dublin, Ireland, ChannelSight helps drive sales and improve user experience through its Where To Buy Technology.

CropX develops AI-driven, cloud-based software solutions integrated with data from proprietary and third-party sources. Its platform boosts crop yield (up to 15%) and saves water (up to 50%), pesticide use (up to 20%), fertilizer use (up to 20%), while also reducing energy and labor costs. With global deployments on over 5,000 farms in 70 countries, CropX is trusted by farmers worldwide.

Blackwood Seven A/S is a Copenhagen-based company that offers an automated media allocation platform designed to enhance the effectiveness of advertising campaigns across various media channels, both online and offline. Founded in 2013, it specializes in video and audio media investments for dynamic businesses. The company employs predictive analytics, utilizing machine learning and artificial intelligence, to optimize media spending and improve return on investment by 15-25%. Its cloud-based platform allows for real-time modeling and comprehensive evaluation of marketing efforts, providing insights into the impact of historical spending and the effectiveness of different media channels. Blackwood Seven has additional locations in Munich, Los Angeles, New York, and Barcelona, serving a diverse clientele looking to maximize their media investments.

LiquidM Technology, established in 2013, is a Berlin-based company that operates as a subsidiary of Smart AdServer SAS. It specializes in providing a single, intuitive platform for advertising and campaign management, primarily focused on mobile display media. The company's modular, cloud-based software enables agencies and trading desks to customize their ad tech infrastructure, offering greater efficiency, control, and insights into media planning and buying. LiquidM's platform is white-labeled, agnostic to third-party integrations, and supports real-time bidding, targeting, and inventory procurement.

Rockley Photonics Limited, founded in 2013 and based in London, United Kingdom, specializes in developing silicon photonics technologies for diverse applications. The company focuses on creating integrated optical modules, sensors, and comprehensive solutions that cater to high-volume and dynamic market sectors. Rockley aims to revolutionize mobile health monitoring and machine vision with its next-generation sensing platforms, while also providing high-speed solutions for data communications. By leveraging its innovative photonic integrated circuits and associated modules, Rockley is positioned to address a wide array of vertical applications, believing that photonics will become as ubiquitous as microelectronics in the future. The company combines hardware with supporting electronics, software, application algorithms, and AI platforms, establishing a robust foundation for future developments across multiple industries.

Sckipio Corporation is a semiconductor company based in Ramat Gan, Israel, specializing in G.fast technology to deliver ultra high-speed broadband solutions. Founded in 2012, Sckipio produces G.fast-based modems that enable telecommunications companies to provide broadband speeds of up to one Gbps per subscriber. The company focuses on applications such as fiber-to-the-distribution-point, multi-dwelling units, and mobile backhaul. Sckipio is notable for being the first semiconductor firm to specialize in G.fast technology, contributing significantly to the development of the ITU standard, with over 20% of the standard originating from its technical expertise. The company's award-winning G.fast solutions are designed to facilitate rapid broadband access using existing wiring, thus enhancing connectivity for businesses and consumers alike.